Navigation Links
PDL BioPharma Provides Third Quarter 2013 Revenue Guidance of $97 Million
Date:9/9/2013

INCLINE VILLAGE, Nev., Sept. 9, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the third quarter ending September 30, 2013, of approximately $97 million, as compared with actual revenue of $85 million for the third quarter of 2012, an approximate 14 percent increase.

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO )

The forecasted growth in revenues is driven by increased second quarter 2013 sales for Avastin®, Herceptin®, Lucentis®, Xolair®, Kadcyla®, Perjeta®, and Actemra® for which PDL receives royalties in the third quarter of 2013.  Sales of Avastin®, Herceptin®, Lucentis®, Xolair®, Perjeta®, and Kadcyla® (the Genentech Products) are subject to a tiered royalty rate for product that is made or sold in the United States and a flat royalty rate of three percent for product that is manufactured and sold outside of the United States (ex-US manufactured and sold).  The net sales thresholds and the applicable royalty rates for the Genentech Products are outlined below:   Genentech Products Made or Sold in US

Royalty RateNet sales up to $1.5 billion

3.0%Net sales between $1.5 billion and up to $2.5 billion

2.5%Net sales between $2.5 billion and up to $4.0 billion

2.0%Net sales exceeding $4.0 billion

1.0%Genentech Products Made and Sold ex-USNet sales

3.0%The third quarter royalty payment received from Genentech included royalties based on worldwide sales.

Revenue guidance for t
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... TAMPA, Fla. , July 28, 2015  For ... by their researchers, physicians and other inventors can be ... to market is difficult, and successes are rare. ... wants to change that. Medical Device ... technology licensed from universities, hospitals and physicians. MDI develops, ...
(Date:7/28/2015)... PLEASANTON, Calif. , July 28, 2015 /PRNewswire/ ... tremendous burden that pressure ulcers place on the ... are a leading threat to modern quality healthcare. ... Human Services, Agency for Healthcare Research and Quality ... system more than $11 billion a year. The ...
(Date:7/28/2015)... 2015 Mike Rowe , spokesperson and reality ... Neighbor Pharmacy,s 2015 ThoughtSpot conference and tradeshow, ... Las Vegas, Nev. Best ... It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent a ... heroes" – people whose hard work, sacrifice and value aren,t ...
Breaking Medicine Technology:Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2
... (NYSE: SHP ) ("ShangPharma" or the "Company"), ... outsourcing company, today announced shareholder resolutions adopted at its ... today. ShangPharma,s shareholders adopted the following ... 1. THAT the 2011 Share Incentive ...
... 2011 Young Innovations, Inc. (NASDAQ - YDNT) today announced ... a live and on-demand web cast conference call on Thursday, ... audio broadcast of the call will be available through InterCall ... will also be available through the Company,s website, www.ydnt.com ...
Cached Medicine Technology:ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2Young Innovations, Inc. Provides 3rd Quarter Conference Call Details 2
(Date:7/29/2015)... DC (PRWEB) , ... July 29, 2015 , ... ... aluminum-related illnesses is seeking funding for a study on the potentially lifesaving impact ... Research Institute today . , The research proposal is based on a ...
(Date:7/29/2015)... ... , ... One may not expect to encounter a kickball game or the ... was happening on the campus of Piedmont Crossing , a local 60-acre retirement ... Only , a five-star childcare center which operates on the same campus. As many ...
(Date:7/28/2015)... Falls Church, VA (PRWEB) , ... July 29, 2015 , ... ... **FDAnews Webinar**, Aug. 18, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline ... biotech, what they can — and can’t — say about it is tightly regulated ...
(Date:7/28/2015)... , ... July 29, 2015 , ... The insurance telematics ... automakers. This would allow insurers to access the on-board vehicle data and better understand ... when it comes to sharing vehicle data. However times are changing and automakers realize ...
(Date:7/28/2015)... ... 2015 , ... A skin cancer screening program offered by the American Society ... for “helping to make the world a better place.” , The Choose Skin Health ... Society of Association Executives. Power of A recognizes organizations annually that “distinguish themselves with ...
Breaking Medicine News(10 mins):Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3
... may be increasing the drug resistance across the world., ... in the journal The Lancet, worldwide resistance to drugs ... 12% since the mid-nineties., ,Adamantanes have been used ... 30 years. Previous surveillance studies have identified a low ...
... companies, said Wednesday it had tied up with private ... over 100 cities. // , ,Under the agreement, ... 240 WebWorld cyber stores in 105 cities to offer ... access to the Apollo Telemedicine Networking Foundation (ATNF), said ...
... Institute of Technology Sleep Laboratory had reported that children ... may need more sleep than others instead of drugs ... is considered an issue of over alertness and nervousness, ... the use of stimulant medications (such as Ritalin) has ...
... branded Zidovudine in US has lead to approval of FDA ... and can be imported from other countries. ,Zidovudine ... of AIDS, the drug prevents the replication of the virus ... The drug is also used in combination with other anti-retroviral ...
... disease which afflicts hundreds of elderly people may be a ... keep patients mentally agile and slow the crippling illness, say ... and not a normal process of ageing with phases of ... is past, the person slowly goes blank," N.M. Narula, president ...
... of the heart may be responsible for causing heart ... State University Dorothy M. Davis Heart and Lung Research ... (RyRs) malfunction in the failing heart. The RyRs form ... prevent the heart from contracting effectively and relaxing adequately. ...
Cached Medicine News:Health News:Children With ADHD May Just Be Sleepy 2Health News:Active Lifestyle Helps To Slowdown Illness In Alzheimer's Patients 2Health News:Defect In Cardiac Cells Lead To Heart Failures 2
... lead family features St. Jude ... The lead is available in ... and silicone (IsoFlex S lead) ... models, and multiple lead lengths, ...
... Veriteq's Refrigerator and Freezer Monitoring ... monitoring system for refrigerators and ... install. Using a building's existing ... Freezer monitoring solution automates the ...
Antiseptic - Antibacterial Sudsing Cleanser...
HIBICLENS' non-drying, low skin irritation potential promotes compliance with the frequent hand washing associated with today's clinical protocols....
Medicine Products: